These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 7752661)
1. Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents. Lynch JJ; Baskin EP; Nutt EM; Guinosso PJ; Hamill T; Salata JJ; Woods CM J Cardiovasc Pharmacol; 1995 Feb; 25(2):336-40. PubMed ID: 7752661 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499. Baskin EP; Lynch JJ J Cardiovasc Pharmacol; 1994 Aug; 24(2):199-208. PubMed ID: 7526051 [TBL] [Abstract][Full Text] [Related]
3. [3H]dofetilide binding: biological models that manifest solely the high or the low affinity binding site. Fiset C; Feng ZP; Wang L; Sheldon RS; Duff HJ J Mol Cell Cardiol; 1996 May; 28(5):1085-96. PubMed ID: 8762045 [TBL] [Abstract][Full Text] [Related]
4. Identification of a specific radioligand for the cardiac rapidly activating delayed rectifier K+ channel. Chadwick CC; Ezrin AM; O'Connor B; Volberg WA; Smith DI; Wedge KJ; Hill RJ; Briggs GM; Pagani ED; Silver PJ Circ Res; 1993 Mar; 72(3):707-14. PubMed ID: 8431994 [TBL] [Abstract][Full Text] [Related]
5. Voltage dependence of cardiac delayed rectifier block by methanesulfonamide class III antiarrhythmic agents. Krafte DS; Volberg WA J Cardiovasc Pharmacol; 1994 Jan; 23(1):37-41. PubMed ID: 7511733 [TBL] [Abstract][Full Text] [Related]
6. Differential atrial versus ventricular activities of class III potassium channel blockers. Baskin EP; Lynch JJ J Pharmacol Exp Ther; 1998 Apr; 285(1):135-42. PubMed ID: 9536003 [TBL] [Abstract][Full Text] [Related]
7. High- and low-affinity sites for [3H]dofetilide binding to guinea pig myocytes. Duff HJ; Feng ZP; Sheldon RS Circ Res; 1995 Oct; 77(4):718-25. PubMed ID: 7554118 [TBL] [Abstract][Full Text] [Related]
8. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079 [TBL] [Abstract][Full Text] [Related]
10. Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide. Lee KS; Tsai TD; Lee EW Eur J Pharmacol; 1993 Mar; 234(1):43-53. PubMed ID: 8472760 [TBL] [Abstract][Full Text] [Related]
11. Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects. Yang T; Snyders DJ; Roden DM Circulation; 1995 Mar; 91(6):1799-806. PubMed ID: 7882490 [TBL] [Abstract][Full Text] [Related]
12. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B. Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780 [TBL] [Abstract][Full Text] [Related]
13. Vascular effects of class-III antiarrhythmic drugs: chromanol 293B, but not dofetilide blocks the smooth muscle delayed rectifier K+ channel. Karle CA; Bauer A; Weretka S; Zitron E; Abushi A; Kreye VA; Schoels W Basic Res Cardiol; 2002 Jan; 97(1):17-25. PubMed ID: 11998973 [TBL] [Abstract][Full Text] [Related]
14. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro. Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377 [TBL] [Abstract][Full Text] [Related]
15. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Jurkiewicz NK; Sanguinetti MC Circ Res; 1993 Jan; 72(1):75-83. PubMed ID: 8417848 [TBL] [Abstract][Full Text] [Related]
16. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization. Varro A; Baláti B; Iost N; Takács J; Virág L; Lathrop DA; Csaba L; Tálosi L; Papp JG J Physiol; 2000 Feb; 523 Pt 1(Pt 1):67-81. PubMed ID: 10675203 [TBL] [Abstract][Full Text] [Related]
17. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o. Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of action potential prolongation by RP 58866 and its active enantiomer, terikalant. Block of the rapidly activating delayed rectifier K+ current, IKr. Jurkiewicz NK; Wang J; Fermini B; Sanguinetti MC; Salata JJ Circulation; 1996 Dec; 94(11):2938-46. PubMed ID: 8941124 [TBL] [Abstract][Full Text] [Related]
19. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle. Yang T; Tande PM; Refsum H J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590 [TBL] [Abstract][Full Text] [Related]
20. Kinetics of rate-dependent shortening of action potential duration in guinea-pig ventricle; effects of IK1 and IKr blockade. Williams BA; Dickenson DR; Beatch GN Br J Pharmacol; 1999 Mar; 126(6):1426-36. PubMed ID: 10217537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]